Company: NGVT
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001653477-25-000127
Chunk: 46

Company: Ingevity Corp
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 46
---
 financial performance of our reportable segments. We continue to include undistributed earnings or loss, distributions, amortization or accretion of basis differences, and other-

28

INGEVITY CORPORATIONNotes to the Condensed Consolidated Financial StatementsSeptember 30, 2025(Unaudited)

than-temporary impairments for equity method investments that we believe are directly attributable to the operational performance of such investments, in our reportable segment results. Refer to Note 4, under the section: Strategic Investments, for more information.Three Months Ended September 30,Nine Months Ended September 30,In millions2025202420252024Performance Materials$— $— $— $(0.1)Performance Chemicals— — — — Advanced Polymer Technologies— 2.2 2.5 2.2 (Gain) loss on strategic investments$— $2.2 $2.5 $2.1 (7) Charges represent legal and other professional service fees as well as incremental proxy solicitation costs related to a proxy contest. (8) Charges represent professional service fees related to a review of the company's portfolio.(9) Includes indirect costs previously allocated to the Divestiture that are not eligible for discontinued operations accounting treatment. Three Months Ended September 30,Nine Months Ended September 30,In millions2025202420252024Cost of sales$1.4 $2.9 $4.3 $8.7 Selling, general, and administrative expenses2.7 2.9 7.5 9.0 Other (income) expense, net0.1 0.5 (0.1)0.8 Indirect costs allocated to Divestiture$4.2 $6.3 $11.7 $18.5 Depreciation and amortizationThree Months Ended September 30,Nine Months Ended September 30,In millions2025202420252024Performance Materials$11.3 $9.7 $31.1 $29.0 Performance Chemicals6.4 6.1 18.3 18.3 Advanced Polymer Technologies8.9 7.9 24.9 23.0 Indirect costs allocated to Divestiture  (1)1.1 1.5 3.1 4.7 Total depreciation and amortization$27.7 $25.